Priority areas in the assessment and treatment of CF exacerbations: Location, duration, inflammation

Acute pulmonary exacerbations of cystic fibrosis (CF) are common events that impact CF patients ’ quality of life and are associated with increased mortality [1]. Although these events are common, many unanswered questions persist regarding the optimal treatment duration, location of treatment and appropriate measurements of their outcomes. In this issue of the journal, four papers focus on different aspects of how CF pulmonary exacerbations are diagnosed and treated. Nicholson et al. [2] presents a systematic review of exacerbation literature, spanning all years up to 2016, just before the landmark STOP2 study [3].
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Tags: Editorial Source Type: research